Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	3.37	50.96	49.29
Graham Fair Price	-10.20	31.09	34.62
PEG	129.78	-0.77	0.33
Price/Book	10.99	1.42	1.28
Price/Cash Flow	-63.42	34.72	94.89
Prices/Earnings	39.35	15.30	10.98
Price/Sales	13.57	24.74	21.78
Price/FCF	-63.42	34.72	94.89
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	9.74	0.57	0.52
Operating Margin	5.06	0.52	0.49
ROA	-19.56	0.01	0.01
ROE	0.03	0.02	-20.35
ROIC	0.02	0.01	-18.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	0.01	160.98
Dividends QOQ	< 0.005	< 0.005	-0.03
EBIT QOQ	-0.03	0.03	3.33
EPS QOQ	0.33	-0.20	-39.35
FCF QOQ	1.33	2.05	54.02
Revenue QOQ	0.04	-0.02	-61.64
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	62.34	56.25	-9.76
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.44	0.43	-2.22
Quick Ratio	0.52	0.59	14.42
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	42.68	42.95	0.62
Cash	0.58	0.42	-26.81
Capex	-1.55	-1.01	34.69
Free Cash Flow	0.58	1.76	205.27
Revenue	2.52	2.47	-1.67
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.63	0.71	13.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	18.58	17.61	-5.23
Naive Interpretation	Member

06 - Financial Health · Bad

Rating